DISTINCTIVE FEATURES OF CANCER CELL METABOLISM: METABOLIC REPROGRAMMING AS A STRATEGY FOR SURVIVAL AND PROLIFERATION

Authors

  • Qo‘shshayeva Mahliyo Bobirjonovna 3rd-year Student, Faculty of Medicine Tashkent State Medical University Tashkent, Uzbekistan

Keywords:

cancer metabolism, metabolic reprogramming, Warburg effect, glycolysis, glutamine metabolism, mitochondrial metabolism, lipid metabolism, metabolic plasticity, tumor microenvironment, oxidative stress.

Abstract

Cancer is traditionally characterized by uncontrolled cellular proliferation, but malignant transformation is accompanied by an equally profound reorganization of cellular metabolism. Cancer cells modify the utilization of glucose, amino acids, lipids, and mitochondrial substrates to satisfy the extraordinary demands of continuous growth. The classical Warburg effect, characterized by increased glucose consumption and lactate production despite the availability of oxygen, represents one of the most recognized metabolic features of malignant cells. However, contemporary understanding indicates that cancer metabolism is substantially more complex and adaptable than aerobic glycolysis alone. Tumor cells can combine glycolysis with mitochondrial oxidative phosphorylation, increase glutamine utilization, remodel lipid synthesis, alter amino acid metabolism, and strengthen antioxidant systems. These adaptations provide not only energy but also the molecular building blocks required for nucleic acid, protein, and membrane synthesis. Furthermore, metabolic products released by cancer cells can reshape the tumor microenvironment and influence immune-cell activity. This article examines the major biochemical characteristics of cancer cell metabolism and emphasizes metabolic plasticity as a central mechanism of tumor survival. Understanding these adaptations may contribute to the development of more selective metabolic interventions and personalized therapeutic strategies in oncology.

References

Hammond, N. G., Cameron, R. B., & Faubert, B. (2024). Beyond glucose and Warburg: Finding the sweet spot in cancer metabolism models. npj Metabolic Health and Disease, 2, 11.

Jin, J., Byun, J. K., Choi, Y. K., et al. (2023). Targeting glutamine metabolism as a therapeutic strategy for cancer. Experimental & Molecular Medicine, 55, 706–715.

Ni, X., Lu, C. P., Xu, G. Q., et al. (2024). Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy. Acta Pharmacologica Sinica, 45, 1533–1555.

Chen, J., Cui, L., Lu, S., et al. (2024). Amino acid metabolism in tumor biology and therapy. Cell Death & Disease, 15, 42.

Demicco, M., Liu, X. Z., Leithner, K., et al. (2024). Metabolic heterogeneity in cancer. Nature Metabolism.

Tate, E. W., Soday, L., de la Lastra, A. L., et al. (2024). Protein lipidation in cancer: Mechanisms, dysregulation and emerging drug targets. Nature Reviews Cancer, 24, 240–260.

Downloads

Published

2026-08-23

How to Cite

Qo‘shshayeva Mahliyo Bobirjonovna. (2026). DISTINCTIVE FEATURES OF CANCER CELL METABOLISM: METABOLIC REPROGRAMMING AS A STRATEGY FOR SURVIVAL AND PROLIFERATION. IQRO , 23(01), 387–393. Retrieved from https://wordlyknowledge.uz/index.php/iqro/article/view/8938